[{"NetIncomeLoss_1_Q2_USD":-59832000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2591751.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":13.71,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-38108000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":6887000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":274000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2123000.0,"InterestPaidNet_2_Q2_USD":6365000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":15881000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GeneralAndAdministrativeExpense_1_Q2_USD":11263000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":22609000.0,"AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_0_Q2_USD":63466000.0,"MarketableSecuritiesCurrent_0_Q2_USD":63466000.0,"RestrictedCashCurrent_0_Q2_USD":566000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AssetsCurrent_0_Q2_USD":416987000.0,"OperatingLeaseExpense_1_Q2_USD":1100000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":0.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":8821000.0,"ShareBasedCompensation_2_Q2_USD":16762000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":12.89,"OperatingLeaseExpense_2_Q2_USD":2200000.0,"Assets_0_Q2_USD":432510000.0,"CommonStockSharesIssued_0_Q2_shares":75988241.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2063000.0,"ResearchAndDevelopmentInProcess_1_Q2_USD":15000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":45000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":271000.0,"FairValueEquityLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":63466000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1127000.0,"OperatingLeaseLiability_0_Q2_USD":9568000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-115000.0,"InterestPayableCurrent_0_Q2_USD":1058000.0,"CommonStockValue_0_Q2_USD":8000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":8.15,"OtherNonoperatingIncomeExpense_1_Q2_USD":457000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":606000.0,"ProceedsFromStockPlans_2_Q2_USD":759000.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q2_shares":1153292.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-342000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":74672882.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":74384805.0,"EarningsPerShareBasic_1_Q2_USD":-0.8,"EarningsPerShareBasic_2_Q2_USD":-1.58,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":10695000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":12.56,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":4431654.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-46000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":397000.0,"FairValueEquityLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"Liabilities_0_Q2_USD":211817000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":915414000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":6165000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":342453000.0,"OtherAssetsNoncurrent_0_Q2_USD":1070000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-6631000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":842000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-59716000.0,"RealizedInvestmentGainsLosses_2_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1045000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":44318000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":86145000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-4258000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":1447260.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-117798000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":387000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1373000.0,"CommonStockSharesAuthorized_0_Q2_shares":700000000.0,"InterestExpense_2_Q2_USD":9614000.0,"NonoperatingIncomeExpense_1_Q2_USD":-4236000.0,"NonoperatingIncomeExpense_2_Q2_USD":-8674000.0,"AccountsPayableCurrent_0_Q2_USD":895000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":5333000.0,"LiabilitiesCurrent_0_Q2_USD":29982000.0,"InterestExpense_1_Q2_USD":4834000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3579000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":74384805.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-106346000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":162000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-210000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8054000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":62000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":74672882.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":116000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":343019000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-192000.0,"NetIncomeLoss_2_Q2_USD":-117473000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5632000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_1_Q2_USD":1100000.0,"OperatingLeasePayments_2_Q2_USD":2100000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10502000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":109643.0,"ShortTermLeaseCost_2_Q2_USD":21000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":43000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.07,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":621000.0,"LongTermDebtNoncurrent_0_Q2_USD":28905000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":286000.0,"ShortTermLeaseCost_1_Q2_USD":12000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-325000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3465000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":49923000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":8054000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":16762000.0,"PreferredStockSharesAuthorized_0_Q2_shares":70000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":8695000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":432510000.0,"OperatingLeaseCost_1_Q2_USD":1038000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":9097000.0,"OperatingLeaseCost_2_Q2_USD":2076000.0,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.7,"InvestmentIncomeInterest_1_Q2_USD":141000.0,"InvestmentIncomeInterest_2_Q2_USD":334000.0,"OperatingIncomeLoss_1_Q2_USD":-55596000.0,"OperatingIncomeLoss_2_Q2_USD":-108799000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.61,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3403000.0,"OperatingExpenses_2_Q2_USD":108799000.0,"OperatingExpenses_1_Q2_USD":55596000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.8,"EarningsPerShareDiluted_2_Q2_USD":-1.58,"CommonStockSharesOutstanding_0_Q2_shares":74834952.0,"ProceedsFromConvertibleDebt_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-143601000.0,"LeaseCost_1_Q2_USD":1050000.0,"LeaseCost_2_Q2_USD":2097000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-695003000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":10435930.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":3284000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-115000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":63404000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":940000.0,"StockholdersEquity_0_Q2_USD":220693000.0,"ProfitLoss_2_Q2_USD":-117473000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2146000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2074000.0,"Ticker":"GOSS","CIK":"1728117","name":"GOSSAMER BIO, INC.","OfficialName":"Gossamer Bio Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"635524809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]